» Articles » PMID: 30425186

Uncoupling Protein 4 () Gene Variability in Neurodegenerative Disorders: Further Evidence of Association in Frontotemporal Dementia

Overview
Specialty Geriatrics
Date 2018 Nov 15
PMID 30425186
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Ongoing research suggests that mitochondrial dysfunction is a common hallmark in neurodegenerative diseases, pointing to mitochondrial uncoupling process as a critical player. We recently reported that rs9472817-C/G, an intronic variant of neuronal mitochondrial uncoupling protein-4 () gene affects the risk of late onset Alzheimer's disease (LOAD), and that the variant's effect is strongly dependent on -ε4 status. Here, we extended our analysis to a cohort of 751 subjects including late-onset familial and sporadic cases of frontotemporal dementia (FTD; 213), Parkinson disease (PD;96), and 442 healthy controls. In all subgroups, carriers of -ε4 allele were at higher risk of disease. Regarding the rs9472817, no association was detected in familial FTD and both subgroups of PD patients. In sporadic FTD, as in LOAD, we found that the C allele increased the risk of disease of about 1.51-fold in a dose-dependent manner (p=0.013) independently from that conferred by -ε4. Expression quantitative trait loci (eQTL) data of different brain regions suggest that rs9472817 likely exerts its effect by a cis-regulatory mechanism involving modulation of . If validated, the involvement of UCP4 in both FTD and LOAD might indicate interesting shared etiological factors which might give future therapeutic clues.

Citing Articles

Association of Apolipoprotein E4-related Microvascular Disease in the Alzheimer's Disease Hippocampal CA1 Stratum Radiatum.

Wang H, Zhang Z, Sittirattanayeunyong S, Hongpaisan J Neuroscience. 2023; 526:204-222.

PMID: 37385335 PMC: 10528415. DOI: 10.1016/j.neuroscience.2023.06.019.


Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.

Cacabelos R, Naidoo V, Martinez-Iglesias O, Corzo L, Cacabelos N, Pego R Methods Mol Biol. 2022; 2547:275-387.

PMID: 36068470 DOI: 10.1007/978-1-0716-2573-6_13.


Ageing related thyroid deficiency increases brain-targeted transport of liver-derived ApoE4-laden exosomes leading to cognitive impairment.

Zhang M, Gong W, Zhang D, Ji M, Chen B, Chen B Cell Death Dis. 2022; 13(4):406.

PMID: 35468877 PMC: 9039072. DOI: 10.1038/s41419-022-04858-x.


Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application.

Wang M, Song W, Ming C, Wang Q, Zhou X, Xu P Mol Neurodegener. 2022; 17(1):17.

PMID: 35236372 PMC: 8889402. DOI: 10.1186/s13024-022-00517-z.


mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder.

Perluigi M, Di Domenico F, Barone E, Butterfield D Free Radic Biol Med. 2021; 169:382-396.

PMID: 33933601 PMC: 8145782. DOI: 10.1016/j.freeradbiomed.2021.04.025.


References
1.
Liu D, Chan S, de Souza-Pinto N, Slevin J, Wersto R, Zhan M . Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromolecular Med. 2006; 8(3):389-414. DOI: 10.1385/NMM:8:3:389. View

2.
Hroudova J, Singh N, Fisar Z . Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease. Biomed Res Int. 2014; 2014:175062. PMC: 4036420. DOI: 10.1155/2014/175062. View

3.
Berridge M . Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion. 2012; 7(1):2-13. PMC: 3609045. DOI: 10.4161/pri.21767. View

4.
Silveri M . Frontotemporal dementia to Alzheimer's disease. Dialogues Clin Neurosci. 2007; 9(2):153-60. PMC: 3181848. View

5.
Ramsden D, Ho P, Ho J, Liu H, So D, Tse H . Human neuronal uncoupling proteins 4 and 5 (UCP4 and UCP5): structural properties, regulation, and physiological role in protection against oxidative stress and mitochondrial dysfunction. Brain Behav. 2012; 2(4):468-78. PMC: 3432969. DOI: 10.1002/brb3.55. View